The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 1.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 6%. Our forward projection puts the odds of a 10% gain over the next month near 8%.
The Gabelli Equity Trust Inc.
GAB · the NYSE · USD
The Gabelli Equity Trust Inc.
FAIL · Does not pass the screenAt the last full screen
2026-09-07
Screened 2026-09-07 · the tape above runs as of 22:12 UTC · 11 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its markdown label.
The Gabelli Equity Trust Inc. holds its Markdown at $5.67. Consolidating, no directional conviction, held for 264 days.
| Phase | Markdown · caution |
| Quantitative state | Consolidating, no directional conviction, held for 264 days |
| Price at the screen | $5.67 |
| Valuation | 5.79 trailing · N/A forward price to earnings |
| Values screen | FAIL · score 30.0 |
| Beta | 0.74 |
Five Screens, Shown in Full
Does not pass. Prohibited keyword in sector/industry: financial services
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Excluded | Core business clean | Prohibited keyword in sector/industry: financial services | Fail |
| Debt load | Excluded | Below 33% | Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | Excluded | Below 33% | Interest-bearing cash and securities are of assets, above the one-third limit. | Fail |
| Receivables | Excluded | Below 49% | Money owed to the company is of assets, above the 49% limit. | Fail |
| Revenue purity | Excluded | Below 5% | of revenue comes from non-compliant sources, over the 5% line. | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Business, in Plain Words| Trailing P/E | 5.8xvery cheap relative to earnings |
| EPS, trailing | 0.98 |
| Revenue growth | +19.4%steady growth |
| Profit margin | 847.5%highly profitable on every dollar of sales |
| Return on equity | 15.8%a solid return on shareholder capital |
| Dividend yield | 1,062.00% |
| Debt to equity | 0.05minimal debt: a conservative balance sheet |
| Current ratio | 1.73healthy short-term liquidity |
| Beta | 0.74steadier than the market |
| 52-week range | 5.28 - 6.31 |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeGAB trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 6%. Our forward projection puts the odds of a 10% gain over the next month near 8%.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 6%. Our forward projection puts the odds of a 10% gain over the next month near 8%.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $5.59 | -0.8% | · | $992 | -0.8% |
| 2 months | $5.59 | -0.8% | · | $992 | -0.8% |
| 3 months | $5.54 | +0.1% | $0.15 | $1,028 | +2.8% |
| 6 months | $5.81 | -4.6% | $0.30 | $1,005 | +0.5% |
| 1 year | $5.25 | +5.6% | $0.60 | $1,169 | +16.9% |
| 2 years | $4.45 | +24.6% | $1.19 | $1,513 | +51.3% |
| 3 years | $4.08 | +35.8% | $1.78 | $1,794 | +79.4% |
| 5 years | $4.33 | +28.2% | $3.00 | $1,976 | +97.6% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever GAB does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.